Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them

A. Scherpereel (Lille, France)

Source: International Congress 2014 – Mesothelioma: a never-ending story
Session: Mesothelioma: a never-ending story
Session type: Symposium
Number: 387

WebcastSlide presentationMultimedia files

Rating: 3
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Scherpereel (Lille, France). Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them. International Congress 2014 – Mesothelioma: a never-ending story

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Bernard Yung - 02.11.2014 15:35
Informative thank you.
You must Login to comment this presentation.


Related content which might interest you:
Approaches to radiological staging of mesothelioma relating to modern treatment modalities
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Malignant mesothelioma: new treatment advances, including targeted therapies
Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care
Year: 2021


From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


Combination immunotherapy in mesothelioma: managing expectations and new toxicities
Source: Virtual Congress 2021 – Lung cancer grand round
Year: 2021


Combined interventional diagnostic modalities
Source: ERS Skills Course 2016
Year: 2016

Regional chemotherapy: a new combined modality approach
Source: Annual Congress 2004 - Lung metastases
Year: 2004

Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Safety and effectiveness of flexible endobronchial cryotherapy as a diagnostic and concurrently therapeutic modality
Source: Annual Congress 2010 - Airway patency: the role of interventional bronchoscopy
Year: 2010

Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021


Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014



The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Four-month regimens: are they feasible?
Source: International Congress 2015 – Tuberculosis: short-course chemotherapy
Year: 2015



New molecular-directed therapies for mesothelioma: have there been any advances?
Source: International Congress 2014 – Mesothelioma: a never-ending story
Year: 2014



Combined modality treatment for NSCLC
Source: Annual Congress 2007 - PG7 - Thoracic oncology: nonsmall cell lung cancer
Year: 2007

Screening of lung cancer: imaging modalities
Source: Annual Congress 2009 - PG2 Core Curriculum Postgraduate Course: Lung cancer imaging: case and problem based
Year: 2009



Rationalising combined use of interventional bronchoscopic modalities
Source: School Course 2014 - Interventional Bronchoscopy
Year: 2014

Multimodal imaging approaches in suspected and confirmed lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


A new definition of multimodality treatment
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016